Shares of Chromocell Therapeutics Co. (NYSE:CHRO – Get Free Report) fell 8.2% during trading on Friday . The stock traded as low as $1.57 and last traded at $1.57. 5,935 shares changed hands during ...

Equities research analysts at HC Wainwright reduced their Q1 2025 earnings per share estimates for shares of Aligos Therapeutics in a report issued on Tuesday, March 11th. HC Wainwright analyst E.

Candel Therapeutics, Inc. ( ($CADL) ) has released its Q4 earnings. Here is a breakdown of the information Candel Therapeutics, Inc. presented to ...

We recently published a list of Top 10 Insider Purchases Last Month. In this article, we are going to take a look at where ...

A study shows that high-grade glioma tumor cells harboring DNA alterations in the gene PDGFRA responded to the drug avapritinib, which is already approved by the United States Food and Drug ...